Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice

Authors :: R.J. Andrade
F. Gea
J. Llaneras
F. Jorquera
Rosa Maria Morillas
Javier García-Samaniego
Javier Crespo
Xavier Torras
Miguel A. Serra
Sabela Lens
JoséA. Cabezas
I. Fernández
Belén Ruiz-Antorán
Juan Turnes
Juan Manuel Pascasio
B. Sacristan
Javier Ampuero
J.M. Moreno
Esther Molina
José Luis Calleja Panero
Jose Ramon Salcines
Miguel Fernández Bermejo
M. Diago
Lucia Bonet
Martín Prieto
M.H. Conde
F.S. Royuela
Diego Rincón
Source :: Journal of Hepatology, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: chemistry.chemical_compound
Hepatology
chemistry
Genotype 1b
business.industry
Ribavirin
Immunology
Medicine
DIRECT ACTING ANTIVIRALS
business
Virology

Full Text Access

Tools